Todd E Schlesinger MD

Dermatology•Charleston, SC

Dermatologic Surgery

Director at Dermatology & Laser Center of Charleston

Join to View Full Profile

2180 Henry Tecklenburg DrCharleston, SC 29414
Phone+1 843-556-8886
Fax+1 843-556-8886

Education & Training

Cleveland Clinic FoundationResidency, Dermatology, 1994 - 1998
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1994

Certifications & Licensure

FL State Medical License 1998 - 2027
SC State Medical License 1998 - 2027
PA State Medical License 1997 - 2026
NY State Medical License 2010 - 2012
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FAAD) American Academy of Dermatology
Fellow (FASDS) American Society for Dermatologic Surgery

Clinical Trials

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
Plaque Psoriasis Study in Pediatric Subjects Start of enrollment: 2014 Jul 01
Completed
Phase 4
Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris Start of enrollment: 2014 Sep 01
Completed
Not Applicable
Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea Start of enrollment: 2017 Dec 06
Completed
Phase 4
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Start of enrollment: 2018 Sep 17
Completed
Phase 2
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Start of enrollment: 2019 Mar 18
Terminated
Phase 2
Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period Start of enrollment: 2019 Sep 16
Completed
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment Start of enrollment: 2023 Nov 06
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: poole...
Andrew Blauvelt, Leon Kircik, Todd Schlesinger, Evangeline Pierce, Russel Burge
The Journal of Dermatological Treatment. 2025-12-01
A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of 10% Aminolevulinic Acid Gel in the Expanded Field-directed Treatment of Acti...
Joel L Cohen, John H Tu, Megan P Couvillion, S Sasha Jazayeri, Nathalie C Zeitouni
The Journal of Clinical and Aesthetic Dermatology. 2025-04-01
Managing Advanced Basal Cell Carcinoma: A Guide for the Dermatology Clinician.
Joshua Burshtein, Todd Schlesinger
The Journal of Clinical and Aesthetic Dermatology. 2025-03-01

Lectures

Clinical Trials in Dermatology
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Authored Content

AAD Preview: What’s New in the Management of Advanced Skin Cancer?March 2022

Press Mentions

Dermatologist Terrence a. Cronin Jr., MD, Named New AAD PresidentMarch 17th, 2023
Five Hot Things Patients Are Asking for This WinterJanuary 27th, 2023
Treating Skin Cancers in the Immunotherapy EraDecember 19th, 2022
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow
American Society for Dermatologic Surgery - ASDS
Fellow